Bei Shi Lee

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Structure Activity Relationship

Human Immunodeficiency Virus

Antiretroviral Therapy

Top Venues

RSC medicinal chemistry

Nature communications

Expert opinion on investigational drugs

Nanyang Technological University (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Nanyang Technological University

Singapore

BSC :: School of Biological Sciences

Publications

Bei Shi Lee, Kevin Pethe
Telacebec: an investigational antibacterial for the treatment of tuberculosis (TB). Expert opinion on investigational drugs 31 (2) (2022)
Rui Liu, Lowell Markley, Patricia A Miller, Scott Franzblau, Gauri Shetye, Rui Ma, Karin Savková, Katarína Mikušová, Bei Shi Lee, Kevin Pethe, Garrett C Moraski, Marvin J Miller
Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds. RSC medicinal chemistry 12 (1) (2021)
Sarah M Hopfner, Bei Shi Lee, Nitin P Kalia, Marvin J Miller, Kevin Pethe, Garrett C Moraski
Structure guided generation of thieno[3,2-d]pyrimidin-4-amine Mycobacterium tuberculosis bd oxidase inhibitors. RSC medicinal chemistry 12 (1) (2021)
Jared S Mackenzie, Dirk A Lamprecht, Rukaya Asmal, John H Adamson, Khushboo Borah, Dany J V Beste, Bei Shi Lee, Kevin Pethe, Simon Rousseau, Inna V Krieger, James C Sacchettini, Joel N Glasgow, Adrie J C Steyn
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. Nature communications 11 (1) (2020)